Traumatology, Orthopedics, Surgery

Maxitran solution for injection 100 mg/ml in ampoules 5 ml No. 5

Link to instruction in PDF format

Registration number :MA No. UA/18255/02/01

Dosage form:Solution for injection

Active substance:tranexamic acid

Composition :Each ml of the solution for injection contains 100 mg of tranexamic acid; excipients: water for injection.

Therapeutic indications :

  • haemorrhage or risk of haemorrhage with increased fibrinolysis, both generalized and local, in adults and children over 1 year of age. Specific indications include: haemorrhages caused by increased general or local fibrinolysis, such as: menorrhagia and metrorrhagia;
  • gastrointestinal bleeding;
  • haemorrhagic disorders of the urinary tract occurred in connection with surgical intervention on the prostate gland or as a result of surgical intervention or procedures on the urinary tract;
  • otolaryngological (removal of adenoids, tonsillectomy) and dental (extraction of teeth) surgical interventions;
  • gynaecological surgeries or complications in obstetric practice;
  • thoracic, abdominal and other major surgical interventions, for example, cardiovascular surgery;
  • control of haemorrhages in connection with the administration of a fibrinolytic drug product;

Shelf life :2 роки

Other in the therapeutic group

Traumatology, Orthopedics, Surgery

Nalbuphine-Microkhim solution for injection 10 mg/ml in ampoules 1 ml No. 10